Northstar Node

Principal Investigators:
Gavin Bart, MD, PhD [email]
Minneapolis Medical Research Foundation
701 Park Avenue
Minneapolis, MN 55415

Anne Joseph, MD, MPH [email]
University of Minnesota
Department of Medicine
Minneapolis, MN 55415

Related Resources

Node website
NIDA website

The Northstar Node joined the NIDA Clinical Trials Network in 2015. It comprises a group of healthcare providers in and around Minneapolis, MN. At the core of their mission is the commitment to advancing the understanding and management of substance use disorders. The Northstar team, led by distinguished experts in the field of addiction medicine collaborates with a network of clinicians, researchers, and healthcare professionals. Together, they work towards integrating the latest scientific findings into practical, effective treatment strategies that address the complexities of addiction.

Grantee Institutions: Minneapolis Medical Research Foundation and University of Minnesota

Protocol Involvement

• CTN-0068: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
• CTN-0070-Ot: Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot
• CTN-0074: Primary Care Opioid Use Disorder (PROUD) Treatment Trial
• CTN-0076-Ot: Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR (COMPUTE)
• CTN-0087: A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration
• CTN-0095-A-1: Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder
• CTN-0095-A-2: Reducing Stigma Toward People with Opioid Use Disorder Among Primary Care Clinicians
• CTN-0095: Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)
• CTN-0096: Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives
• CTN-0098: Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE)
• CTN-0099: Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)
• CTN-0109: Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2)
• CTN-0112: Optimal Policies to Improve Methadone Maintenance Adherence Longterm (OPTIMMAL)
• CTN-0123: Facebook Intervention for Preventing Opioid Relapse Among American Indian Women
• CTN-0124: Assessment and Design of a Cost-Effective Collaborative MOUD Delivery System
• CTN-0127: Engaging African American Faith-Based Leaders in a Substance Use Learning Collaborative
• CTN-0131: Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder (MOUD)– A Pragmatic Hybrid Effectiveness/Implementation Trial